Glucosylceramidase (3.2.1.45)

Industry

CPC
C12Y302/01045

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12YENZYMES C12Y302/00Hydrolases acting on glycosyl compounds

Current Industry

C12Y302/01045Glucosylceramidase (3.2.1.45)

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Polynucleotides
- Patent number 12,331,331
- Issue date Jun 17, 2025
- SPUR THERAPEUTICS LIMITED
- Amit Nathwani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Lysosomal enzymes modified by cell based glycoengineering
- Patent number 12,325,871
- Issue date Jun 10, 2025
- University of Copenhagen
- Claus Kristensen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
ICAM-1 targeted fusion enzymes
- Patent number 12,319,719
- Issue date Jun 3, 2025
- University of Maryland, College Park
- Silvia Muro
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Glycosylated lysosomal proteins, method of production and uses
- Patent number 12,247,215
- Issue date Mar 11, 2025
- eleva GmbH
- Paulina Dabrowska-Schlepp
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for the treatment of steatosis-associated...
- Patent number 12,171,731
- Issue date Dec 24, 2024
- Duke University
- Dwight D. Koeberl
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for CNS delivery of arylsulfatase A
- Patent number 12,168,041
- Issue date Dec 17, 2024
- Takeda Pharmaceutical Company Limited
- Nazila Salamat-Miller
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for CNS delivery of heparan N-sulfatase
- Patent number 12,161,702
- Issue date Dec 10, 2024
- Takeda Pharmaceutical Company Limited
- Farah Natoli
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for treatment of GCase related disease states
- Patent number 12,133,880
- Issue date Nov 5, 2024
- Children's Hospital Medical Center
- Ying Sun
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for CNS delivery of iduronate-2-sulfatase
- Patent number 12,121,569
- Issue date Oct 22, 2024
- Takeda Pharmaceutical Company Limited
- Gaozhong Zhu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Integrated continuous manufacturing of therapeutic protein drug sub...
- Patent number 12,110,312
- Issue date Oct 8, 2024
- Genzyme Corporation
- Konstantin Konstantinov
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Grant
Methods for treating neurological symptoms associated with lysosoma...
- Patent number 12,083,115
- Issue date Sep 10, 2024
- Genzyme Corporation
- Nigel Patrick Somerville Crawford
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapy for neurodegenerative disorders
- Patent number 12,049,626
- Issue date Jul 30, 2024
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for the treatment of cytoplasmic glycogen...
- Patent number 12,036,190
- Issue date Jul 16, 2024
- Duke University
- Priya Kishnani
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 11,993,790
- Issue date May 28, 2024
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
ICAM-1 targeted fusion enzymes
- Patent number 11,912,745
- Issue date Feb 27, 2024
- University of Maryland, College Park
- Silvia Muro
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 11,903,985
- Issue date Feb 20, 2024
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Fusion proteins comprising enzyme replacement therapy enzymes
- Patent number 11,866,742
- Issue date Jan 9, 2024
- Denali Therapeutics Inc.
- Anastasia Henry
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 11,807,849
- Issue date Nov 7, 2023
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 11,802,294
- Issue date Oct 31, 2023
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modified recombinant lysosomal alpha-galactosidase A and aspartylgl...
- Patent number 11,708,569
- Issue date Jul 25, 2023
- University of Copenhagen
- Claus Kristensen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for the treatment of steatosis-associated...
- Patent number 11,690,812
- Issue date Jul 4, 2023
- Duke University
- Dwight D. Koeberl
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 11,661,585
- Issue date May 30, 2023
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 11,655,460
- Issue date May 23, 2023
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 11,613,737
- Issue date Mar 28, 2023
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
In vitro and in vivo enrichment strategy targeting lymphocytes deri...
- Patent number 11,597,917
- Issue date Mar 7, 2023
- The Medical College of Wisconsin, Inc.
- Jeffrey A. Medin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for treating Gaucher disease
- Patent number 11,571,466
- Issue date Feb 7, 2023
- Takeda Pharmaceutical Company Limited
- Peter Francis Daniel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CNS delivery of therapeutic agents
- Patent number 11,471,516
- Issue date Oct 18, 2022
- Shire Human Genetic Therapies, Inc.
- Pericles Calias
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glycosylated lysosomal proteins, method of production and uses
- Patent number 11,401,563
- Issue date Aug 2, 2022
- eleva GmbH
- Paulina Dabrowska-Schlepp
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Progranulin (PGRN) fragments and derivatives for treatment or allev...
- Patent number 11,390,656
- Issue date Jul 19, 2022
- New York University
- Chuanju Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Gene therapy for lysosomal storage diseases
- Patent number 11,369,693
- Issue date Jun 28, 2022
- Genzyme Corporation
- James Dodge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
NOVEL IN VITRO AND IN VIVO ENRICHMENT STRATEGY TARGETING LYMPHOCYTE...
- Publication number 20250188428
- Publication date Jun 12, 2025
- The Medical College of Wisconsin, Inc.
- Jeffrey A. Medin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE A
- Publication number 20250161417
- Publication date May 22, 2025
- Takeda Pharmaceutical Company Limited
- Nazila Salamat-Miller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING GAUCHER DISEASE AND GBA-PARKINSON’S DISEASE
- Publication number 20250152747
- Publication date May 15, 2025
- Genzyme Corporation
- Swathi AYLOO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF TREATING NEURODEGENERATIVE DISORDERS
- Publication number 20250152744
- Publication date May 15, 2025
- Genzyme Corporation
- Shyam RAMACHANDRAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS COMPRISING GLUCOCEREBROCIDASE AND METHODS OF USE THEREOF
- Publication number 20250152680
- Publication date May 15, 2025
- M6P THERAPEUTICS, INC.
- Robert Russell GOTSCHALL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GLYCOSYLATED PROTEIN HAVING GLUCOCEREBROSIDASE ACTIVITY
- Publication number 20250145978
- Publication date May 8, 2025
- Nippon Shokubai Co., Ltd.
- Daisuke TATEIWA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PROTEIN HAVING GLUCOCEREBROSIDASE ACTIVITY AND METHOD FOR PRODUCING...
- Publication number 20250145979
- Publication date May 8, 2025
- Nippon Shokubai Co., Ltd.
- Daisuke TATEIWA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS OF USING TWO-PROMOTER VECTOR FOR TREATMENT...
- Publication number 20250137012
- Publication date May 1, 2025
- M6P THERAPEUTICS, INC.
- Hung DO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT GLUCOCEREBROSIDASE PROTEIN HAVING IMPROVED ENZYME ACTIV...
- Publication number 20250129351
- Publication date Apr 24, 2025
- Nippon Shokubai Co., Ltd.
- Daisuke TATEIWA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR CNS DELIVERY OF IDURONATE-2-SULFATASE
- Publication number 20250121040
- Publication date Apr 17, 2025
- Takeda Pharmaceutical Company Limited
- Gaozhong Zhu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
AAV-BASED MODULATION OF GBA1 AND RELATED COMPOSITIONS AND USES THEREOF
- Publication number 20250082686
- Publication date Mar 13, 2025
- Aspen Neuroscience, Inc.
- Andres BRATT-LEAL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS...
- Publication number 20250049955
- Publication date Feb 13, 2025
- VOYAGER THERAPEUTICS, INC.
- Mathieu Emmanuel NONNENMACHER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT AAV VECTORS FOR TREATING NEURODEGENERATIVE DISORDERS
- Publication number 20250041456
- Publication date Feb 6, 2025
- SHANGHAI VITALGEN BIOPHARMA CO., LTD.
- Yezheng TAO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FUSION PROTEINS TARGETED TO THE CENTRAL NERVOUS SYSTEM
- Publication number 20250034538
- Publication date Jan 30, 2025
- HOFFMANN-LA ROCHE INC.
- Per-Ola Freskgard
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENE THERAPY FOR NEURODEGENERATIVE DISORDERS
- Publication number 20250011783
- Publication date Jan 9, 2025
- Prevail Therapeutics, Inc.
- Asa ABELIOVICH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Integrated Continuous Manufacturing of Therapeutic Protein Drug Sub...
- Publication number 20240417427
- Publication date Dec 19, 2024
- Genzyme Corporation
- Konstantin Konstantinov
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Application
Methods and Compositions for the Treatment of Cytoplasmic Glycogen...
- Publication number 20240398729
- Publication date Dec 5, 2024
- DUKE UNIVERSITY
- Priya Kishnani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ICAM-1 TARGETED FUSION ENZYMES
- Publication number 20240327475
- Publication date Oct 3, 2024
- University of Maryland, College Park
- Silvia Muro
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
POLYPEPTIDE
- Publication number 20240261433
- Publication date Aug 8, 2024
- FREELINE THERAPEUTICS LIMITED
- Fabrizio COMPER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A GENETICALLY MODIFIED CELL LINE PRODUCING A RECOMBINANT GLYCOPROTE...
- Publication number 20240167010
- Publication date May 23, 2024
- WUXI BIOLOGICS IRELAND LIMITED
- Liqin XU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYSTEMS AND METHODS FOR PROTEIN EXPRESSION
- Publication number 20240141373
- Publication date May 2, 2024
- Excepgen Inc.
- Barbara MERTINS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENE THERAPIES FOR LYSOSOMAL DISORDERS
- Publication number 20240123003
- Publication date Apr 18, 2024
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ASSAY FOR MEASURING POTENCY OF GENE THERAPY DRUG PRODUCT
- Publication number 20240044869
- Publication date Feb 8, 2024
- Prevail Therapeutics, Inc.
- Mary NG
- G01 - MEASURING TESTING
Information Patent Application
DOPAMINERGIC NEURONS COMPRISING MUTATIONS AND METHODS OF USE THEREOF
- Publication number 20240034992
- Publication date Feb 1, 2024
- FUJIFILM Cellular Dynamics, Inc.
- Deepika RAJESH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
LYSOSOMAL ENZYMES MODIFIED BY CELL BASED GLYCOENGINEERING
- Publication number 20230416715
- Publication date Dec 28, 2023
- UNIVERSITY OF COPENHAGEN
- Claus KRISTENSEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Novel In Vitro and In Vivo Enrichment Strategy Targeting Lymphocyte...
- Publication number 20230332112
- Publication date Oct 19, 2023
- The Medical College of Wisconsin, Inc.
- Jeffrey A. Medin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENE THERAPIES FOR LYSOSOMAL DISORDERS
- Publication number 20230310654
- Publication date Oct 5, 2023
- Prevail Therapeutics, Inc.
- Asa ABELIOVICH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Methods and Compositions for the Treatment of Steatosis-Associated...
- Publication number 20230285328
- Publication date Sep 14, 2023
- DUKE UNIVERSITY
- Dwight D. Koeberl
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Methods and Compositions for the Treatment of Steatosis-Associated...
- Publication number 20230285329
- Publication date Sep 14, 2023
- DUKE UNIVERSITY
- Dwight D. Koeberl
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
A GENETICALLY MODIFIED CELL LINE PRODUCING A RECOMBINANT GLYCOPROTE...
- Publication number 20230287378
- Publication date Sep 14, 2023
- WUXI BIOLOGICS IRELAND LIMITED
- Liqin XU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Glucosylceramidase (3.2.1.45)

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Polynucleotides

Lysosomal enzymes modified by cell based glycoengineering

ICAM-1 targeted fusion enzymes

Glycosylated lysosomal proteins, method of production and uses

Methods and compositions for the treatment of steatosis-associated...

Methods and compositions for CNS delivery of arylsulfatase A

Methods and compositions for CNS delivery of heparan N-sulfatase

Compositions and methods for treatment of GCase related disease states

Methods and compositions for CNS delivery of iduronate-2-sulfatase

Integrated continuous manufacturing of therapeutic protein drug sub...

Methods for treating neurological symptoms associated with lysosoma...

Gene therapy for neurodegenerative disorders

Methods and compositions for the treatment of cytoplasmic glycogen...

Gene therapies for lysosomal disorders

ICAM-1 targeted fusion enzymes

Gene therapies for lysosomal disorders

Fusion proteins comprising enzyme replacement therapy enzymes

Gene therapies for lysosomal disorders

Gene therapies for lysosomal disorders

Modified recombinant lysosomal alpha-galactosidase A and aspartylgl...

Methods and compositions for the treatment of steatosis-associated...

Gene therapies for lysosomal disorders

Gene therapies for lysosomal disorders

Gene therapies for lysosomal disorders

In vitro and in vivo enrichment strategy targeting lymphocytes deri...

Compositions and methods for treating Gaucher disease

CNS delivery of therapeutic agents

Glycosylated lysosomal proteins, method of production and uses

Progranulin (PGRN) fragments and derivatives for treatment or allev...

Gene therapy for lysosomal storage diseases

Patents Applicationslast 30 patents

NOVEL IN VITRO AND IN VIVO ENRICHMENT STRATEGY TARGETING LYMPHOCYTE...

METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE A

METHODS OF TREATING GAUCHER DISEASE AND GBA-PARKINSON’S DISEASE

METHODS OF TREATING NEURODEGENERATIVE DISORDERS

COMPOSITIONS COMPRISING GLUCOCEREBROCIDASE AND METHODS OF USE THEREOF

GLYCOSYLATED PROTEIN HAVING GLUCOCEREBROSIDASE ACTIVITY

PROTEIN HAVING GLUCOCEREBROSIDASE ACTIVITY AND METHOD FOR PRODUCING...

COMPOSITIONS AND METHODS OF USING TWO-PROMOTER VECTOR FOR TREATMENT...

RECOMBINANT GLUCOCEREBROSIDASE PROTEIN HAVING IMPROVED ENZYME ACTIV...

METHODS AND COMPOSITIONS FOR CNS DELIVERY OF IDURONATE-2-SULFATASE

AAV-BASED MODULATION OF GBA1 AND RELATED COMPOSITIONS AND USES THEREOF

COMPOSITONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS...

RECOMBINANT AAV VECTORS FOR TREATING NEURODEGENERATIVE DISORDERS

FUSION PROTEINS TARGETED TO THE CENTRAL NERVOUS SYSTEM

GENE THERAPY FOR NEURODEGENERATIVE DISORDERS

Integrated Continuous Manufacturing of Therapeutic Protein Drug Sub...

Methods and Compositions for the Treatment of Cytoplasmic Glycogen...

ICAM-1 TARGETED FUSION ENZYMES

POLYPEPTIDE

A GENETICALLY MODIFIED CELL LINE PRODUCING A RECOMBINANT GLYCOPROTE...

SYSTEMS AND METHODS FOR PROTEIN EXPRESSION

GENE THERAPIES FOR LYSOSOMAL DISORDERS

ASSAY FOR MEASURING POTENCY OF GENE THERAPY DRUG PRODUCT

DOPAMINERGIC NEURONS COMPRISING MUTATIONS AND METHODS OF USE THEREOF

LYSOSOMAL ENZYMES MODIFIED BY CELL BASED GLYCOENGINEERING

Novel In Vitro and In Vivo Enrichment Strategy Targeting Lymphocyte...

GENE THERAPIES FOR LYSOSOMAL DISORDERS

Methods and Compositions for the Treatment of Steatosis-Associated...

Methods and Compositions for the Treatment of Steatosis-Associated...

A GENETICALLY MODIFIED CELL LINE PRODUCING A RECOMBINANT GLYCOPROTE...